NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT01037049 2018-09-17Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksRoyal Marsden NHS Foundation TrustPhase 2 Unknown237 enrolled